// App-Quantinova.ai

11375 : miR-145 Is a Key Regulator of Cardiac Myofibroblast Differentiation

Researchers

Presenter

  • Shu-hong Li

Principal Investigators

  • Jian Guo

  • Richard D Weisel

  • Ren-Ke Li

Medical Centers

  • Toronto General Hospital/Research Institute (UHN), Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • MicroRNA 143

  • Kruppel Like Factor 5

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved